Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 637 to 639 of 639 entries
Sorted by: Best Match Show Resources per page
Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.

Lancet (London, England)

Rickard CM, Marsh NM, Larsen EN, McGrail MR, Graves N, Runnegar N, Webster J, Corley A, McMillan D, Gowardman JR, Long DA, Fraser JF, Gill FJ, Young J, Murgo M, Alexandrou E, Choudhury MA, Chan RJ, Gavin NC, Daud A, Palermo A, Regli A, Playford EG.
PMID: 33865494
Lancet. 2021 Apr 17;397(10283):1447-1458. doi: 10.1016/S0140-6736(21)00351-2.

BACKGROUND: The optimal duration of infusion set use to prevent life-threatening catheter-related bloodstream infection (CRBSI) is unclear. We aimed to compare the effectiveness and costs of 7-day (intervention) versus 4-day (control) infusion set replacement to prevent CRBSI in patients...

Cite
Rickard CM, Marsh NM, Larsen EN, et al. Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial. Lancet. 2021;397(10283):1447-1458doi: 10.1016/S0140-6736(21)00351-2.
Rickard, C. M., Marsh, N. M., Larsen, E. N., McGrail, M. R., Graves, N., Runnegar, N., Webster, J., Corley, A., McMillan, D., Gowardman, J. R., Long, D. A., Fraser, J. F., Gill, F. J., Young, J., Murgo, M., Alexandrou, E., Choudhury, M. A., Chan, R. J., Gavin, N. C., Daud, A., Palermo, A., Regli, A., & Playford, E. G. (2021). Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial. Lancet (London, England), 397(10283), 1447-1458. https://doi.org/10.1016/S0140-6736(21)00351-2
Rickard, Claire M, et al. "Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial." Lancet (London, England) vol. 397,10283 (2021): 1447-1458. doi: https://doi.org/10.1016/S0140-6736(21)00351-2
Rickard CM, Marsh NM, Larsen EN, McGrail MR, Graves N, Runnegar N, Webster J, Corley A, McMillan D, Gowardman JR, Long DA, Fraser JF, Gill FJ, Young J, Murgo M, Alexandrou E, Choudhury MA, Chan RJ, Gavin NC, Daud A, Palermo A, Regli A, Playford EG. Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial. Lancet. 2021 Apr 17;397(10283):1447-1458. doi: 10.1016/S0140-6736(21)00351-2. PMID: 33865494.
Copy Download .nbib Format: NLM
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids.

Cell stem cell

Jansen J, Reimer KC, Nagai JS, Varghese FS, Overheul GJ, de Beer M, Roverts R, Daviran D, Fermin LAS, Willemsen B, Beukenboom M, Djudjaj S, von Stillfried S, van Eijk LE, Mastik M, Bulthuis M, Dunnen WD, van Goor H, Hillebrands JL, Triana SH, Alexandrov T, Timm MC, van den Berge BT, van den Broek M, Nlandu Q, Heijnert J, Bindels EMJ, Hoogenboezem RM, Mooren F, Kuppe C, Miesen P, Grünberg K, Ijzermans T, Steenbergen EJ, Czogalla J, Schreuder MF, Sommerdijk N, Akiva A, Boor P, Puelles VG, Floege J, Huber TB, van Rij RP, Costa IG, Schneider RK, Smeets B, Kramann R.
PMID: 35032430
Cell Stem Cell. 2021 Dec 25; doi: 10.1016/j.stem.2021.12.010. Epub 2021 Dec 25.

Kidney failure is frequently observed during and after COVID-19, but it remains elusive whether this is a direct effect of the virus. Here, we report that SARS-CoV-2 directly infects kidney cells and is associated with increased tubule-interstitial kidney fibrosis...

Cite
Jansen J, Reimer KC, Nagai JS, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2021;doi: 10.1016/j.stem.2021.12.010.
Jansen, J., Reimer, K. C., Nagai, J. S., Varghese, F. S., Overheul, G. J., de Beer, M., Roverts, R., Daviran, D., Fermin, L. A. S., Willemsen, B., Beukenboom, M., Djudjaj, S., von Stillfried, S., van Eijk, L. E., Mastik, M., Bulthuis, M., Dunnen, W. D., van Goor, H., Hillebrands, J. L., Triana, S. H., Alexandrov, T., Timm, M. C., van den Berge, B. T., van den Broek, M., Nlandu, Q., Heijnert, J., Bindels, E. M. J., Hoogenboezem, R. M., Mooren, F., Kuppe, C., Miesen, P., Grünberg, K., Ijzermans, T., Steenbergen, E. J., Czogalla, J., Schreuder, M. F., Sommerdijk, N., Akiva, A., Boor, P., Puelles, V. G., Floege, J., Huber, T. B., van Rij, R. P., Costa, I. G., Schneider, R. K., Smeets, B., & Kramann, R. (2021). SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell stem cell, . https://doi.org/10.1016/j.stem.2021.12.010
Jansen, Jitske, et al. "SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids." Cell stem cell vol. (2021). doi: https://doi.org/10.1016/j.stem.2021.12.010
Jansen J, Reimer KC, Nagai JS, Varghese FS, Overheul GJ, de Beer M, Roverts R, Daviran D, Fermin LAS, Willemsen B, Beukenboom M, Djudjaj S, von Stillfried S, van Eijk LE, Mastik M, Bulthuis M, Dunnen WD, van Goor H, Hillebrands JL, Triana SH, Alexandrov T, Timm MC, van den Berge BT, van den Broek M, Nlandu Q, Heijnert J, Bindels EMJ, Hoogenboezem RM, Mooren F, Kuppe C, Miesen P, Grünberg K, Ijzermans T, Steenbergen EJ, Czogalla J, Schreuder MF, Sommerdijk N, Akiva A, Boor P, Puelles VG, Floege J, Huber TB, van Rij RP, Costa IG, Schneider RK, Smeets B, Kramann R. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2021 Dec 25; doi: 10.1016/j.stem.2021.12.010. Epub 2021 Dec 25. PMID: 35032430.
Copy Download .nbib Format: NLM
Accessing depth-resolved high spatial frequency content from the optical coherence tomography signal.

Scientific reports

Alexandrov S, Arangath A, Zhou Y, Murphy M, Duffy N, Neuhaus K, Shaw G, McAuley R, Leahy M.
PMID: 34429483
Sci Rep. 2021 Aug 24;11(1):17123. doi: 10.1038/s41598-021-96619-7.

Optical coherence tomography (OCT) is a rapidly evolving technology with a broad range of applications, including biomedical imaging and diagnosis. Conventional intensity-based OCT provides depth-resolved imaging with a typical resolution and sensitivity to structural alterations of about 5-10 microns....

Cite
Alexandrov S, Arangath A, Zhou Y, et al. Accessing depth-resolved high spatial frequency content from the optical coherence tomography signal. Sci Rep. 2021;11(1):17123doi: 10.1038/s41598-021-96619-7.
Alexandrov, S., Arangath, A., Zhou, Y., Murphy, M., Duffy, N., Neuhaus, K., Shaw, G., McAuley, R., & Leahy, M. (2021). Accessing depth-resolved high spatial frequency content from the optical coherence tomography signal. Scientific reports, 11(1), 17123. https://doi.org/10.1038/s41598-021-96619-7
Alexandrov, Sergey, et al. "Accessing depth-resolved high spatial frequency content from the optical coherence tomography signal." Scientific reports vol. 11,1 (2021): 17123. doi: https://doi.org/10.1038/s41598-021-96619-7
Alexandrov S, Arangath A, Zhou Y, Murphy M, Duffy N, Neuhaus K, Shaw G, McAuley R, Leahy M. Accessing depth-resolved high spatial frequency content from the optical coherence tomography signal. Sci Rep. 2021 Aug 24;11(1):17123. doi: 10.1038/s41598-021-96619-7. PMID: 34429483; PMCID: PMC8385072.
Copy Download .nbib Format: NLM
Showing 637 to 639 of 639 entries